| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,429 |
18,017 |
$1.03M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,767 |
4,803 |
$361K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,710 |
11,358 |
$298K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,445 |
898 |
$262K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,133 |
3,931 |
$130K |
| 80305 |
|
26,468 |
15,686 |
$122K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,975 |
1,479 |
$52K |
| 86769 |
|
2,200 |
1,336 |
$39K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
6,592 |
3,820 |
$38K |
| 82075 |
|
7,340 |
4,465 |
$30K |
| 81025 |
|
11,824 |
6,855 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,713 |
1,610 |
$27K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,358 |
725 |
$19K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
441 |
202 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,770 |
4,494 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
5,772 |
3,848 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,221 |
624 |
$4K |
| 96127 |
|
875 |
648 |
$2K |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
135 |
106 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
128 |
98 |
$1K |
| 90658 |
|
142 |
115 |
$1K |
| 81003 |
|
1,582 |
731 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,702 |
980 |
$957.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
117 |
68 |
$866.58 |
| 80053 |
Comprehensive metabolic panel |
102 |
55 |
$478.23 |
| 80061 |
Lipid panel |
109 |
51 |
$415.80 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
101 |
54 |
$371.04 |
| 93000 |
|
20 |
19 |
$274.40 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
72 |
31 |
$265.14 |
| 81002 |
|
207 |
107 |
$236.22 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
66 |
29 |
$115.92 |
| 36416 |
|
167 |
124 |
$99.65 |
| 84436 |
|
77 |
32 |
$38.48 |
| J7999 |
Compounded drug, not otherwise classified |
69 |
29 |
$28.75 |
| 84402 |
|
13 |
12 |
$25.34 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
87 |
66 |
$13.20 |
| 81000 |
|
318 |
190 |
$10.12 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
439 |
309 |
$3.22 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
19 |
14 |
$2.66 |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
1,119 |
848 |
$0.00 |
| 96130 |
|
72 |
35 |
$0.00 |
| 99406 |
|
21 |
17 |
$0.00 |